Latest Artificial Intelligence News

Vection Technologies has landed a $1.2 million grant to lead an innovative XR and AI digital twin project aimed at transforming real-time product intelligence in food and beverage manufacturing.

NEXTDC reports a significant 30% jump in contracted utilisation to 228MW, driven by strong AI deployments in Victoria, prompting a $100 million increase in FY25 capital expenditure guidance.

Vicinity Centres reports a robust third quarter for FY25, driven by strong retailer demand and shopper confidence, highlighted by the successful launch of The Market Pavilion at Chadstone.

Vicinity Centres reports a robust third quarter for FY25, buoyed by record visitation at Chadstone’s new Market Pavilion and strong retail sales growth. The company now expects full-year earnings at the top end of guidance, underpinned by resilient portfolio metrics and strategic asset management.

4DMedical has landed a significant commercial contract with Intermountain Health to deploy its FDA-cleared Pulmonary Hypertension Analysis (PHA™) product, marking a key milestone in its U.S. expansion through a strategic Microsoft-backed partnership.

Westpac Banking Corporation reported a slight 1% decline in net profit to $3.3 billion for the first half of 2025, while business and institutional lending grew robustly. The bank maintained a solid capital position and announced a fully franked interim dividend of 76 cents per share.

Opyl Limited has successfully raised $1.5 million through an oversubscribed placement to accelerate the growth of its AI-driven clinical trial platform, Trialkey. The capital injection underscores strong investor confidence as the company prepares for a pivotal expansion phase.

White Energy Company Limited has marked significant progress in its mining exploration and coal technology divisions during the March 2025 quarter, including achieving a key farm-in milestone and raising $3.7 million net from an entitlement offer.

Enlitic reported a 5.8% revenue increase in Q1 CY25, strengthened its collaboration with GE HealthCare, and accelerated integration of Laitek, positioning itself for operational cashflow break-even by the end of 2025.

TrivarX has launched a pivotal mental health clinical trial in partnership with the US Department of Veterans Affairs, leveraging its innovative ECG-based technology to screen for major depressive episodes. The company also secured $2.25 million in funding, positioning it for regulatory milestones ahead.

Strategic Elements Ltd (ASX: SOR) reported meaningful progress in its Energy Ink™ technology and underground mining platform during Q1 2025, while maintaining a robust cash balance and preparing for international collaborations.

ADX Energy reported a 13% rise in Austrian production and a 15% increase in sales revenue for Q1 2025, while Welchau-1 well testing remains suspended pending legal review. The company also secured a key Italian gas exploration permit, positioning for growth across Europe.